Valuation AstraZeneca PLC NYSE

Stocks

Real-time Estimate Cboe BZX Other stock markets 21:30:27 16/06/2026 +03			5-day change	1st Jan Change
178.92 ^USD	+0.93%		-2.36%	+94.33%

08:21am	ASTRAZENECA : Gets a Buy rating from Jefferies	ZD
06-15	UK Shares End Lower as Investors Assess US-Iran Peace Framework	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	275,121	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-4.41%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	294,367	287,126	279,122
Change	-	12.57%	-0.25%	-1.74%	36.64%	-5.41%	-2.46%	-2.79%
P/E Ratio	1,469x	64.1x	35.4x	29.1x	28.4x	22.2x	19.4x	16.7x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.18x	4.46x	3.64x
PEG	-	0x	0.4x	1.6x	0.6x	1x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.34x	4.1x	3.84x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.65x	4.28x	3.9x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	13.2x	11.7x	10.4x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.9x	12.2x	10.8x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28.2x	20.9x	18.3x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.54%	4.78%	5.45%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.337	3.524	3.659
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.88%	1.99%	2.06%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.979	9.145	10.61
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.8%	38.5%	34.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,321	67,157	71,556
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,337	24,470	26,751
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,241	23,587	25,911
Net income ¹	112	3,288	5,961	7,035	10,225	12,488	14,137	16,137
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,245	12,005	4,001
Reference price ²	117.51	135.16	135.02	131.05	185.60	177.38	177.38	177.38
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,550,996	-	-
Announcement Date	2/10/22 A	2/9/23 A	2/8/24 A	2/6/25 A	2/10/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.05x	12.01x	24.74x	0.6%	1,007B
JOHNSON & JOHNSON	25.19x	5.81x	15.79x	2.26%	567B
ABBVIE INC.	27.13x	6.62x	13.53x	3.1%	392B
ROCHE HOLDING AG	17.5x	4.32x	10.61x	3.07%	328B
NOVARTIS AG	20.98x	5.43x	13.17x	2.95%	277B
NOVO NORDISK A/S	12.63x	4.73x	9.67x	3.97%	196B
AMGEN INC.	22.79x	6.1x	10.65x	2.88%	189B
GILEAD SCIENCES, INC.	-44.54x	5.38x	29.66x	2.61%	154B
PFIZER INC.	12.16x	3.18x	7.75x	6.74%	148B
Average	14.10x	5.95x	15.06x	3.13%	362.12B
Weighted average by Cap.	21.93x	7.45x	17.16x	2.35%